Last reviewed · How we verify

NCT03898934: PCOvit-D

Vitamin D Supplementation in PCOS Patients

Completed Phase 4 Last updated 5 May 2022
What this trial tests

Phase 4 trial testing Vitamin D in PCOS in 170 participants. Completed in 31 March 2022.

Timeline
1 April 2019
Primary endpoint
30 March 2022
31 March 2022

Quick facts

Lead sponsorTanta University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment170
Start date1 April 2019
Primary completion30 March 2022
Estimated completion31 March 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 20 to 35, female only, with PCOS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess whether Vitamin D supplementations for patients with polycystic ovary syndrome in conjunction with clomiphene citrate are beneficial or not

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Vitamin D

Trials testing the same drug.

Other recruiting trials for PCOS

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03898934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing